Showing results (491-500 of 2,012) with videos related to
Sort By:
Pageof 202
Annals of Hepatology|June 2, 2026
Quantifying long-term outcomes and risks for living liver donors: a review of the current global experienceAshwin Rammohan, Madhukar S Patel, Ramkiran Cherukuru, et al.Annals of Hepatology|May 27, 2026
Clinical features, treatment strategies and outcomes of hepatocellular carcinoma in association with type 1 Abernethy malformation: an evaluation of a pooled case seriesFred Ahmadi, Vatsal Khanna, Leonid ShambanAnnals of Hepatology|May 19, 2026
Simple model stratifies liver cancer risk in non-cirrhotic chronic hepatitis C patients after viral eradicationYen-Chun Liu, Te-Sheng Chang, Chi-Yi Chen, et al.Annals of Hepatology|May 20, 2026
Hepatocellular Carcinoma in Honduras (2014-2023): Nationwide Trends in Hospital Discharges and MortalityLarissa Acosta Salgado, Daniela Sofia Cruz Betanco, Gisela Pattarone, et al.Annals of Hepatology|May 8, 2026
Development and validation of the HABIT score: a practical and robust tool to predict hepatic steatosis using HbA1c, BMI, and triglycerides in patients with unexplained elevated liver enzymesEike Humbert, Verena Wilkens, Semjon Bugaichuk, et al.Annals of Hepatology|October 22, 2014
Long-delayed gross hematuria due to portal hypertension in an alcoholic cirrhotic patient with ileal conduit urinary diversionFabrizio Dal MoroAnnals of Hepatology|November 6, 2020
Cannabis use may reduce healthcare utilization and improve hospital outcomes in patients with cirrhosisLindsay A Sobotka, Khalid Mumtaz, Alice Hinton, et al.Annals of Hepatology|August 30, 2026
Porto-sinusoidal vascular disorder and sinusoidal obstructive syndrome in patients treated with thiopurines: a systematic reviewArmando Curto, Erica Nicola Lynch, Michele Tanturli, et al.Annals of Hepatology|August 30, 2026
Artificial intelligence in Latin American hepatology: current evidence, implementation barriers, and strategic prioritiesEzequiel Ridruejo, Andreas Teufel, Mario Alvares-da-Silva, et al.Annals of Hepatology|September 14, 2026
Effect of liver function on clinical outcomes in patients with unresectable hepatocellular carcinoma treated with first-line atezolizumab-bevacizumab: an Asia-Pacific multicenter retrospective analysisYeokyeong Shin, Young Jae Kim, David Wai Meng Tai, et al.Pageof 202